{"id":446895,"date":"2020-07-03T10:03:43","date_gmt":"2020-07-03T03:03:43","guid":{"rendered":"https:\/\/www.vibiznews.com\/?p=446895"},"modified":"2020-07-03T10:04:54","modified_gmt":"2020-07-03T03:04:54","slug":"prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma","status":"publish","type":"post","link":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/","title":{"rendered":"Prospek Positif Industri Kesehatan Semester Kedua &#8211; Wawancara bersama Vidjongtius, CEO Kalbe Farma"},"content":{"rendered":"<p style=\"text-align: justify;\">(Vibiznews &#8211; Dialogie &amp; Opinion) Menghadapi semester kedua tahun 2020, Kalbe Farma tetap optimis bahwa bisnis kesehatan akan berkembang.<\/p>\n<p style=\"text-align: justify;\">Vidjongtius, CEO PT Kalbe Farma Tbk menyatakan menghadapi kondisi pandemi saat ini, Portfolio Kalbe yang terdiri dari beberapa divisi, ada yang terdampak, tapi ada juga yang positif.<\/p>\n<p style=\"text-align: justify;\">Seperti bagian Vitamin, Suplemen, Herbal dipastikan besar, bahkan pertumbuhan bisa double karena dibutuhkan masyarakat dengan Health Awareness yang tinggi. Seperti contoh yang terjadi bulan Maret begitu tinggi permintaan obat dan vitamin.<\/p>\n<p style=\"text-align: justify;\">Demikian juga alat kesehatan seperti Masker sudah tersedia dengan baik, sekalipun sempat mahal sekali pada awal pandemi.<\/p>\n<p style=\"text-align: justify;\">Menghadapi kondisi pandemi sekarang ini, Vidjongtius menambahkan bahwa perusahaan Kalbe mengatur portfolio produknya, mana yang diakukan dalam sisa 6 bulan ini di tahun 2020 ini dan mana yang tidak. Dengan mengatur portfolio tersebut maka dapat menopang pertumbuhan bisnis baik untuk top line maupun bottom line<\/p>\n<p style=\"text-align: justify;\">Vidjongtius juga menyatakan bahwa prospek ekspor juga terbuka, terutama ASEAN, sekalipun belum semua negara dibuka tapi sudah mulai ada yang dibuka, dengan membawa produk obat dan vitamin.<\/p>\n<pre><em>Asido Situmorang, Senior Analyst, Vibiz Research Center, Vibiz Consulting<\/em><\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(Vibiznews &#8211; Dialogie &amp; Opinion) Menghadapi semester kedua tahun 2020, Kalbe Farma tetap optimis bahwa bisnis kesehatan akan berkembang. Vidjongtius, CEO PT Kalbe Farma Tbk menyatakan menghadapi kondisi pandemi saat ini, Portfolio Kalbe yang terdiri dari beberapa divisi, ada yang terdampak, tapi ada juga yang positif. Seperti bagian Vitamin, Suplemen, Herbal dipastikan besar, bahkan pertumbuhan [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":446899,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1059,19,89],"tags":[4555,10283],"class_list":["post-446895","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-dialogue-opinion","category-idx-stock","category-media-center","tag-pt-kalbe-farma-tbk-klbf","tag-vidjongtius","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Prospek Positif Industri Kesehatan Semester Kedua - Wawancara bersama Vidjongtius, CEO Kalbe Farma - Vibiznews.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prospek Positif Industri Kesehatan Semester Kedua - Wawancara bersama Vidjongtius, CEO Kalbe Farma - Vibiznews.com\" \/>\n<meta property=\"og:description\" content=\"(Vibiznews &#8211; Dialogie &amp; Opinion) Menghadapi semester kedua tahun 2020, Kalbe Farma tetap optimis bahwa bisnis kesehatan akan berkembang. Vidjongtius, CEO PT Kalbe Farma Tbk menyatakan menghadapi kondisi pandemi saat ini, Portfolio Kalbe yang terdiri dari beberapa divisi, ada yang terdampak, tapi ada juga yang positif. Seperti bagian Vitamin, Suplemen, Herbal dipastikan besar, bahkan pertumbuhan [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/\" \/>\n<meta property=\"og:site_name\" content=\"Vibiznews.com\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-03T03:03:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-03T03:04:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Asido Situmorang\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Asido Situmorang\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/\",\"url\":\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/\",\"name\":\"Prospek Positif Industri Kesehatan Semester Kedua - Wawancara bersama Vidjongtius, CEO Kalbe Farma - Vibiznews.com\",\"isPartOf\":{\"@id\":\"https:\/\/vibiznews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg\",\"datePublished\":\"2020-07-03T03:03:43+00:00\",\"dateModified\":\"2020-07-03T03:04:54+00:00\",\"author\":{\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9\"},\"breadcrumb\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#primaryimage\",\"url\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg\",\"contentUrl\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vibiznews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prospek Positif Industri Kesehatan Semester Kedua &#8211; Wawancara bersama Vidjongtius, CEO Kalbe Farma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vibiznews.com\/#website\",\"url\":\"https:\/\/vibiznews.com\/\",\"name\":\"Vibiznews.com\",\"description\":\"Berita Bisnis | Berita Komoditi | Berita Saham\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vibiznews.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9\",\"name\":\"Asido Situmorang\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g\",\"caption\":\"Asido Situmorang\"},\"description\":\"Asido is now the Senior Research Economic of Vibiz Research Center and Editor in Chief of Vibiznews.com, that makes market analysis (fundamental &amp; technical) and research of the economy and business of Indonesia and globally, as well as other related topics such as capital and money market. He also actively writing hundreds of journals, analytical articles and columns in Vibiznews.com.\",\"sameAs\":[\"http:\/\/www.vibiznews.com\"],\"url\":\"https:\/\/vibiznews.com\/index.php\/author\/asido-situmorang\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prospek Positif Industri Kesehatan Semester Kedua - Wawancara bersama Vidjongtius, CEO Kalbe Farma - Vibiznews.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/","og_locale":"en_US","og_type":"article","og_title":"Prospek Positif Industri Kesehatan Semester Kedua - Wawancara bersama Vidjongtius, CEO Kalbe Farma - Vibiznews.com","og_description":"(Vibiznews &#8211; Dialogie &amp; Opinion) Menghadapi semester kedua tahun 2020, Kalbe Farma tetap optimis bahwa bisnis kesehatan akan berkembang. Vidjongtius, CEO PT Kalbe Farma Tbk menyatakan menghadapi kondisi pandemi saat ini, Portfolio Kalbe yang terdiri dari beberapa divisi, ada yang terdampak, tapi ada juga yang positif. Seperti bagian Vitamin, Suplemen, Herbal dipastikan besar, bahkan pertumbuhan [&hellip;]","og_url":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/","og_site_name":"Vibiznews.com","article_published_time":"2020-07-03T03:03:43+00:00","article_modified_time":"2020-07-03T03:04:54+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg","type":"image\/jpeg"}],"author":"Asido Situmorang","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Asido Situmorang","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/","url":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/","name":"Prospek Positif Industri Kesehatan Semester Kedua - Wawancara bersama Vidjongtius, CEO Kalbe Farma - Vibiznews.com","isPartOf":{"@id":"https:\/\/vibiznews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#primaryimage"},"image":{"@id":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#primaryimage"},"thumbnailUrl":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg","datePublished":"2020-07-03T03:03:43+00:00","dateModified":"2020-07-03T03:04:54+00:00","author":{"@id":"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9"},"breadcrumb":{"@id":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#primaryimage","url":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg","contentUrl":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/07\/maxresdefault.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/vibiznews.com\/index.php\/2020\/07\/03\/prospek-positif-industri-kesehatan-semester-kedua-wawancara-bersama-vidjongtius-ceo-kalbe-farma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vibiznews.com\/"},{"@type":"ListItem","position":2,"name":"Prospek Positif Industri Kesehatan Semester Kedua &#8211; Wawancara bersama Vidjongtius, CEO Kalbe Farma"}]},{"@type":"WebSite","@id":"https:\/\/vibiznews.com\/#website","url":"https:\/\/vibiznews.com\/","name":"Vibiznews.com","description":"Berita Bisnis | Berita Komoditi | Berita Saham","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vibiznews.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9","name":"Asido Situmorang","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vibiznews.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g","caption":"Asido Situmorang"},"description":"Asido is now the Senior Research Economic of Vibiz Research Center and Editor in Chief of Vibiznews.com, that makes market analysis (fundamental &amp; technical) and research of the economy and business of Indonesia and globally, as well as other related topics such as capital and money market. He also actively writing hundreds of journals, analytical articles and columns in Vibiznews.com.","sameAs":["http:\/\/www.vibiznews.com"],"url":"https:\/\/vibiznews.com\/index.php\/author\/asido-situmorang\/"}]}},"_links":{"self":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/446895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/comments?post=446895"}],"version-history":[{"count":1,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/446895\/revisions"}],"predecessor-version":[{"id":446897,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/446895\/revisions\/446897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/media\/446899"}],"wp:attachment":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/media?parent=446895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/categories?post=446895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/tags?post=446895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}